Septem Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2018.
2018 Lucknow, Uttar Pradesh, India Active
Last Updated:
Access Report
About Septem Pharmaceuticals Private Limited

Septem Pharmaceuticals Private Limited, a active private limited company, was established on 26 April 2018 in Lucknow, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24304UP2018PTC103674. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Meraj Ahmad (Director), Suhail Ahmad (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H. No. 61A, K No. 254/2 Govind Vihar, Kamta Chinhat, Lucknow, Uttar Pradesh, 227105.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304UP2018PTC103674

  • Registration Number

    103674

  • Incorporation Date

    26 April 2018

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -91.82%
  • Profit Growth **** -96.71%
  • Ebitda **** -92.84%
  • Net Worth 4.21%
  • Total Assets **** 12.15%
Company report

Septem Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Septem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Septem Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Meraj Ahmad Director 26 Apr 2018 Current
Suhail Ahmad Director 26 Apr 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Septem Pharmaceuticals.

Septem Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 91.82% decrease. The company also saw a substantial fall in profitability, with a 96.71% decrease in profit. The company's net worth moved up by a moderate rise of 4.21%.

Septem Pharmaceuticals revenue growth over time
Septem Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -91.82%
*******
*******
*******
*******
Revenue from Operations
*******
 -91.82%
*******
*******
*******
*******
Total Assets
*******
 12.15%
*******
*******
*******
*******
Profit or Loss
*******
 -96.71%
*******
*******
*******
*******
Net Worth
*******
 4.21%
*******
*******
*******
*******
EBITDA
*******
 -92.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Septem Pharmaceuticals?

Unlock access to Septem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Septem Pharmaceuticals?

Unlock and access historical data on people associated with Septem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Septem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septem Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Septem Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Septem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Septem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was completed.

  • Director Appointment

    Progress on Meraj Ahmad was appointed as a Director was appointed as a Director on 26 Apr 2018 & has been associated with this company since 7 years 10 months . was documented.

  • Director Appointment

    The activity Suhail Ahmad was appointed as a Director was appointed as a Director on 26 Apr 2018 & has been associated with this company since 7 years 10 months . was completed.

  • Company Incorporation

    Septem Pharmaceuticals Private Limited was registered on 26 Apr 2018 with Roc Kanpur & aged 7 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Septem Pharmaceuticals Private Limited?

The CIN of Septem Pharmaceuticals Private Limited is U24304UP2018PTC103674.

Where is Septem Pharmaceuticals Private Limited headquartered?

Septem Pharmaceuticals Private Limited is headquartered at H. No. 61A, K No. 254/2 Govind Vihar, Kamta Chinhat, Lucknow, Uttar Pradesh, 227105.

When was Septem Pharmaceuticals Private Limited incorporated?

Septem Pharmaceuticals Private Limited was incorporated on 26 April 2018.

Who are the current directors of Septem Pharmaceuticals Private Limited?

The current directors of Septem Pharmaceuticals Private Limited are

What is the primary industry of Septem Pharmaceuticals Private Limited?

The primary industry of Septem Pharmaceuticals Private Limited is Pharma.

Is Septem Pharmaceuticals Private Limited a listed company?

Septem Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Septem Pharmaceuticals Private Limited?

The authorized capital of Septem Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available